MARKET

ATRC

ATRC

AtriCure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

75.92
+0.62
+0.82%
After Hours: 75.92 0 0.00% 16:19 06/11 EDT
OPEN
75.10
PREV CLOSE
75.30
HIGH
76.11
LOW
72.69
VOLUME
204.53K
TURNOVER
--
52 WEEK HIGH
80.44
52 WEEK LOW
34.04
MARKET CAP
3.46B
P/E (TTM)
-67.1918
1D
5D
1M
3M
1Y
5Y
These are Wall Street’s top analysts favorite stocks heading into June
TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Deere & Advanced Micro Devices.
CNBC.com · 05/30 12:24
Insider Trends: AtriCure Sees 90 Days of Insider Buying Trend Reducing with Share Sale
MT Newswires · 05/28 16:16
Expert Ratings for AtriCure
Analysts have provided the following ratings for AtriCure (NASDAQ:ATRC) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago
Benzinga · 05/26 12:54
10 Biggest Price Target Changes For Wednesday
Morgan Stanley boosted the price target for Intuit Inc. (NASDAQ: INTU) from $470 to $511. Intuit shares rose 1% to $443.50 in pre-market trading.
Benzinga · 05/26 12:32
SVB Leerink Adjusts AtriCure's Price Target to $95 From $78, Keeps Outperform Rating
MT Newswires · 05/26 11:18
SVB Leerink Maintains Outperform on AtriCure, Raises Price Target to $95
SVB Leerink analyst Danielle Antalffy maintains AtriCure (NASDAQ:ATRC) with a Outperform and raises the price target from $78 to $95.
Benzinga · 05/26 10:09
Oppenheimer Adjusts AtriCure PT to $82 From $75, Maintains Outperform Rating
MT Newswires · 05/20 11:52
--JPMorgan Adjusts AtriCure's Price Target to $81 From $70, Maintains Overweight Rating
MT Newswires · 05/14 12:15
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ATRC. Analyze the recent business situations of AtriCure through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ATRC stock price target is 86.14 with a high estimate of 102.00 and a low estimate of 72.00.
EPS
Institutional Holdings
Institutions: 268
Institutional Holdings: 49.16M
% Owned: 107.74%
Shares Outstanding: 45.63M
TypeInstitutionsShares
Increased
51
5.65M
New
31
971.57K
Decreased
76
2.92M
Sold Out
35
2.64M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.06%
Key Executives
Non-Executive Chairman/Independent Director
B. Kristine Johnson
President/Chief Executive Officer/Director
Michael Carrel
Chief Financial Officer/Senior Vice President
M. Andrew Wade
Chief Financial Officer
Angela Wirick
Chief Operating Officer
Douglas Seith
Chief Technology Officer
Salvatore Privitera
Chief Marketing Officer
Justin Noznesky
Independent Director
Mark Collar
Independent Director
Daniel Florin
Independent Director
Regina Groves
Independent Director
Karen Prange
Independent Director
Sven Wehrwein
Independent Director
Robert White
No Data
  • All
  • Financials
  • Insiders
More
About ATRC
AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion. The Company also sells Lumitip dissectors and the Estech line of reusable cardiac surgery (valve) instruments. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).

Webull offers kinds of AtriCure Inc. stock information, including NASDAQ:ATRC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATRC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATRC stock methods without spending real money on the virtual paper trading platform.